Today’s Rating Alert: N+1 Singer Reconfirms “Corporate” Rating for Abzena Plc (LON:ABZA) Stock

November 30, 2016 - By Vivian Park

Abzena Plc (LON:ABZA) Rating

N+1 Singer reconfirmed their “Corporate” rating on shares of Abzena Plc (LON:ABZA) in analysts report released on Wednesday morning.

Abzena PLC (LON:ABZA) Ratings Coverage

Out of 2 analysts covering Abzena Plc (LON:ABZA), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 100 is the highest target while GBX 98 is the lowest. The GBX 99 average target is 200.64% above today’s (GBX 32.93) stock price. Abzena Plc has been the topic of 12 analyst reports since September 14, 2015 according to StockzIntelligence Inc. On Tuesday, November 29 the stock rating was maintained by FinnCap with “Buy”. The firm has “Buy” rating by N+1 Singer given on Monday, September 21. The stock of Abzena PLC (LON:ABZA) earned “Corporate” rating by N+1 Singer on Tuesday, November 24. The stock has “Corporate” rating given by N+1 Singer on Monday, January 25. The firm earned “Corporate” rating on Thursday, January 7 by N+1 Singer. The rating was maintained by N+1 Singer on Thursday, November 24 with “Corporate”. The company was maintained on Monday, September 14 by N+1 Singer. The firm has “Corporate” rating given on Wednesday, November 30 by N+1 Singer. N+1 Singer maintained the stock with “Buy” rating in Monday, October 12 report. The firm has “Buy” rating by FinnCap given on Friday, November 18.

About 102,500 shares traded hands or 1020.46% up from the average. Abzena PLC (LON:ABZA) has declined 34.34% since May 2, 2016 and is downtrending. It has underperformed by 39.57% the S&P500.

Abzena plc is a life sciences company. The company has a market cap of 45.30 million GBP. The Firm provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It currently has negative earnings. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.

Another recent and important Abzena PLC (LON:ABZA) news was published by which published an article titled: “Abzena plc: Placing to Raise £20 Million and Acquisition” on November 24, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News